Although the target of these studies was the comprehension of the role of GSK3β in bone remodeling with regards to its role in osteoporosis, these observations suggest that GSK3β inhibition, obtained for instance by using lithium chloride (LiCl), might be an interesting putative target also for the therapy of ONJ. The gene discussed is GSK3B; the disease is osteoporosis.